DYNAPHARMA

Dynachem Pharmaceuticals (Export) Ltd Share Price

₹00.00 0.00 (0.00%)

23 Nov, 2024 15:10

SIP TrendupStart SIP in DYNAPHARMA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

SIP Lightning

Smart Investing Starts Here Start SIP with Dynachem Pharmaceuticals (Export) Ltd for Steady Growth!

Invest Now

Dynachem Pharmaceuticals (Export) Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 0
  • P/B Ratio
  • -
  • Average True Range
  • -
  • EPS
  • -
  • Dividend Yield
  • -
  • MACD Signal
  • -
  • RSI
  • -
  • MFI
  • -

Dynachem Pharmaceuticals (Export) Ltd Financials

Dynachem Pharmaceuticals (Export) Ltd Technicals

EMA & SMA

Current Price
₹00.00
(%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

00 Pivot Speed

What's your outlook on Dynachem Pharmaceuticals (Export) Ltd?

You can only vote for once

Dynachem Pharmaceuticals (Export) Ltd F&O

Dynachem Pharmaceuticals (Export) Ltd Shareholding Pattern

No data available.

About Dynachem Pharmaceuticals (Export) Ltd

  • NSE Symbol
  • DYNAPHARMA
  • BSE Symbol
  • 524562
  • ISIN

Similar Stocks to Dynachem Pharmaceuticals (Export) Ltd

Dynachem Pharmaceuticals (Export) Ltd FAQs

Dynachem Pharmaceuticals (Export) Ltd share price is ₹00 As on 23 November, 2024 | 14:56

The Market Cap of Dynachem Pharmaceuticals (Export) Ltd is ₹ Cr As on 23 November, 2024 | 14:56

The P/E ratio of Dynachem Pharmaceuticals (Export) Ltd is As on 23 November, 2024 | 14:56

The PB ratio of Dynachem Pharmaceuticals (Export) Ltd is As on 23 November, 2024 | 14:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23